# Mercedes Tuin

> Mercedes Tuin is a seed investor at BOM backing Biotechnology and Clinical Trials. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BOM](https://shizune.co/investors/profile/brabantse-ontwikkelings-maatschappij-bom)
- Total investments: 1
- Last investment: Mar 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/msetuin/
- Website: http://www.bom.nl

Mercedes Tuin is a seed investor at BOM focused on Biotechnology and Clinical Trials. Mercedes Tuin is the Venture Capital Life Sciences and MedTech at BOM. Mercedes Tuin attended at RSM Erasmus University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 100% |
| Clinical Trials | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| RiboPro | RiboPro is a biotechnology company that specializes in molecular biology, clinical trials, and health diagnostic services. | $1.4M | Seed | Mar 22, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Rockstart](https://shizune.co/investors/profile/rockstart-accelerator) — VC Fund, 1 deal together
- [Vlasroot Group](https://shizune.co/investors/profile/vlasroot-group) — VC Fund, 1 deal together

## About BOM

VC Fund · Tilburg, The Netherlands

BOM invests in innovative start-ups and growth companies. BOM objectives include improved economic growth, increased employment, and solutions to social problems. They offer expertise, resources, and connections through their network to create and finance renewable energy projects.

5 contacts available at BOM.

| Name | Title | Profile |
| --- | --- | --- |
| Gert-Jan Vaessen | Manager | https://shizune.co/investors/profile/gert-jan-vaessen |
| Jeroen Siemes | Senior Investment Manager of Life Sciences and Medtech/Fund to Fund | https://shizune.co/investors/profile/jeroen-siemes |
| Jurgen van Eck | Sr Investment Manager | https://shizune.co/investors/profile/jurgen-van-eck |
| Mercedes Tuin | Sr Investment Manager | https://shizune.co/investors/profile/mercedes-tuin |
| Eelko Brinkhoff | Managing Director Foreign Investments, International Trade and MT member | https://shizune.co/investors/profile/eelko-brinkhoff-abb3 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Mercedes Tuin invest in?

Mercedes Tuin invests primarily in Biotechnology, Clinical Trials and Health Diagnostics startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mercedes Tuin last invest?

The most recent investment recorded for Mercedes Tuin closed in Mar 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co